ALSO READSun Pharmaceutical Industries receives final approval for generic ezetimibe tablets Sun Pharma posts surprise loss in June-quarter Sun Pharma reports quarterly loss after one-off charge Sun Pharma says 2018 sales may fall as U.S. market gets tougher Sun Pharmaceuticals Industries schedules board meeting
Receives copy of EIR from USFDASun Pharmaceuticals Industries has received a communication from the US FDA releasing a copy of the Establishment Inspection Report (EIR) in respect of the inspection of Company's Dadra facility. Earlier, the USFDA had issued Form- 483 observation letter post inspection completed on 13 April 2017.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)